Stanley Goldfarb and Dan Negoianu of the Perelman School of Medicine address urban myths about water consumption.
Health & Medicine
Discovering the step-by-step details of the path embryonic cells take to develop into their final tissue type is the clinical goal of many stem cell biologists.
Penn's Center for Neurodegenerative Disease Research (CNDR) will partner with Johnson & Johnson Pharmaceutical Research and Development, L.L.C., (J&JPRD) to develop algorithms that can identify changes in biomarkers related to disease diagnosis and for monitoring disease progression.
Zachary Meisel of the School of Medicine offers his perspective on a challenge of a Vermont law.
Despite recent concerns that medications for attention deficit hyperactivity disorder (ADHD) could increase the risk of cardiovascular events in children and adolescents, an observational study conducted by researchers at the Perelman School of Medicine at the University of Pennsylvania and HealthCore Inc. finds they are no more likely to die from a severe cardiovascular event than those who do not take the drugs.
Jonathan Moreno of the School of Medicine comments on the “ethical implications of using neuroscience in security activities and military research.”
The School of Medicine receives a $225 million gift from Raymond and Ruth Perelman.